Savchenko A P, Koshumbaeva K M, Sidorenko B A, Samko A N
Kardiologiia. 1986 Oct;26(10):65-9.
The dipyridamole test was performed during diagnostic coronaro-ventriculography in 7 patients showing no angiographic signs of coronary atherosclerosis (group 1) and 15 patients with a 75% stenosis in one or more coronary arteries (group 2). The test provoked an anginal attack in 11 (73%) second-group patients that was accompanied with the emergence or aggravation of asynergy in 10 (67%) or ischemic electrocardiographic changes in 7 (47%). In all cases, the anginal attack was associated with a rise in end diastolic pressure. All first-group patients showed no response to the dipyridamole test as evidenced clinically and electrocardiographically. No asynergic zones were identified on any of the ventriculograms recorded after dipyridamole administration.
在诊断性冠状动脉心室造影期间,对7例无冠状动脉粥样硬化血管造影征象的患者(第1组)和15例一支或多支冠状动脉狭窄75%的患者(第2组)进行了双嘧达莫试验。该试验在11例(73%)第2组患者中诱发了心绞痛发作,其中10例(67%)伴有协同失调的出现或加重,7例(47%)伴有缺血性心电图改变。在所有病例中,心绞痛发作均与舒张末期压力升高有关。所有第1组患者在临床和心电图上均显示对双嘧达莫试验无反应。在给予双嘧达莫后记录的任何心室造影片上均未发现协同失调区。